Conditioned Medium Treatment for the Improvement of Functional Recovery after Spinal Cord Injury: A Meta-Analysis Study. 2024

Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.

BACKGROUND While there is no certain treatment for spinal cord injury (SCI), stem cellbased therapy may be an attractive alternative, but the survival and differentiation of cells in the host tissue are poor. Conditioned medium (CM) has several beneficial effects on cells. OBJECTIVE In this meta-analysis study, we examined the effect of CM on SCI treatment. METHODS After searching on MEDLINE, SCOPUS, EMBASE, and Web of Science, first and secondary screening were performed based on title, abstract, and full text. The data were extracted from the included studies, and meta-analysis was performed using STATA.14 software. A standardized mean difference (SMD) with a 95% confidence interval was used to report findings. Quality control and subgroup analysis were also performed. RESULTS The results from 52 articles and 61 separate experiments showed that CM had a significantly strong effect on improving motor function after SCI (SMD = 2.58; 95% CI: 2.17 to 2.98; p < 0.001) and also analysis of data from 12 articles demonstrated that CM reduced the expression of GFAP marker (SMD = -4.16; p < 0.0001) compared to SCI group without any treatment. Subgroup analysis showed that treatment with CM of neural stem cells was better than CM of mesenchymal stem cells. It was more effective after a mild lesion than a moderate or severe one. The improvement was more pronounced with <4 weeks than >4 weeks follow-up. CONCLUSIONS CM had a significant effect in improving motor function after SCI, especially in cases of mild lesions. It has been observed that if CM originates from the neural stem cells, it has a more significant effect than mesenchymal cells.

UI MeSH Term Description Entries

Related Publications

Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
September 2022, Spine surgery and related research,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
January 2017, Brain research,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
July 2020, International journal of molecular sciences,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
June 2002, American journal of physical medicine & rehabilitation,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
February 1999, Archives of physical medicine and rehabilitation,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
January 2012, PloS one,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
January 2021, BioMed research international,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
September 2018, Anatomy & cell biology,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
April 2000, Nature medicine,
Razieh Hajisoltani, and Mona Taghizadeh, and Michael R Hamblin, and Fatemeh Ramezani
March 2017, Cell transplantation,
Copied contents to your clipboard!